{
    "code": "70000033",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=70000033",
    "time": "2016-05-27 03:36:32",
    "許可證字號": "衛部罕藥輸字第000033號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "114\/09\/01",
    "發證日期": "104\/09\/01",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA07000003303",
    "中文品名": "柯珮鬆注射液20毫克",
    "英文品名": "Copaxone 20mg\/ml, Pre-Filled syringe for Injection",
    "適應症": "Copaxone用於治療首次出現臨床症狀且有MRI為佐證之多發性硬化症病人。復發型多發性硬化症Copaxone，用於減少復發型多發性硬化病人的復發頻率。",
    "劑型": "27D注射液劑",
    "包裝": "1毫升(附針)注射針筒 100支以下盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "GLATIRAMER ACETATE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "620102K944  香港商艾維斯有限公司台灣分公司",
    "申請商地址": "台北市中正區忠孝東路二段116號10樓",
    "主製造廠": {
        "製造廠名稱": "F240037000  TEVA PHARMACEUTICAL INDUSTRIES LTD.",
        "製造廠廠址": "18, ELI HURVITZ STREET, INDUSTRIAL ZONE, KFAR SABA 44102, ISRAEL",
        "製造廠公司地址": "",
        "製造廠國別": "ISRAEL",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200043510",
            "成分名稱": "GLATIRAMER ACETATE",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Copaxone 20mg_PI_201511(Chinese)-104-12-03.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000033&Seq=002&Type=9"
        },
        {
            "title": "020000330001-104-10-28.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000033&Seq=001&Type=9"
        },
        {
            "title": "020000330004-標籤-104-10-28.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000033&Seq=002&Type=8"
        },
        {
            "title": "020000330003-外盒-104-10-28.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000033&Seq=001&Type=8"
        }
    ]
}